Xinxiang Li

机构：Tongji University, Shanghai Medical College of Fudan University, Fudan University Shanghai Cancer Center, Zhongda Hospital Southeast University, Shanghai Cancer Institute, ZheJiang Academy of Agricultural Sciences, Tongji Hospital · ORCID：0000-0002-5902-3659

发表论文 208 篇 · 总被引 6303 次 · h-index 37

代表论文

• The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of colorectal cancer, 2024 update (2024 · 癌症：英文版 · 被引 67)
• Laparoscopy-assisted versus open surgery for low rectal cancer (LASRE): 3-year survival outcomes of a multicentre, randomised, controlled, non-inferiority trial (2024 · ˜The œLancet. Gastroenterology & hepatology · 被引 24)
• Pep2TCR: Accurate prediction of CD4 T cell receptor binding specificity through transfer learning and ensemble approach (2024 · iMetaOmics. · 被引 3)
• Restoring antitumor immunity by reprogramming abnormal lipid metabolism in the tumor microenvironment using irisin-manganese co-loaded nanoparticles (2026 · Acta Biomaterialia · 被引 2)
• Immunotherapy combined with hypofractionated radiotherapy and chemotherapy for locally recurrent rectal cancer (TORCH-R): A prospective, single-arm, two-cohort, phase II trial. (2025 · Journal of Clinical Oncology · 被引 2)
• Elevated CA19-9 within the normal range suggests poorer prognosis in stage II CRC: A retrospective analysis of a large sample in a single center (2024 · Journal of Cancer Research and Therapeutics · 被引 2)